Fletcher Allen Health Care - Medical Center Campus
Burlington, Vermont 05401
0 studies enrolling now · 15 studies all time
What they study most
Cervical Cancer, Colorectal Cancer, Endometrial Cancer, Lymphoma, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Prostate Cancer, Vulvar Cancer
Studies at this site
- Y 90 Ibritumomab Tiuxetan &Rituximab Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma — Completed
- Surgery Versus Internal Radiation in Treating Patients With Stage II Prostate Cancer — Completed
- Genetic Study of Young Patients With Colorectal Cancer — Completed
- Quality of Life in Patients Undergoing Surgery or Brachytherapy for Stage II Prostate Cancer — Completed
- Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer — Status unconfirmed
- Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer — Completed
- Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer — Completed
- Radiation Therapy With or Without Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Cancer of the Vulva — Stopped early
- Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer — Stopped early
- Gemcitabine in Treating Patients With Persistent or Recurrent Cancer of the Cervix — Stopped early
- Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer — Stopped early
- Liposomal Doxorubicin in Treating Patients With Persistent or Recurrent Cancer of the Cervix — Stopped early
- Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Stage I Cancer of the Cervix — Stopped early
- Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer — Stopped early
- Tirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer — Completed